MOKARROMA SHARMIN: Open Payments
NPI 1821263542 · WYLIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $52 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $121 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Renalytix AI, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: ZEPBOUND, SHINGRIX, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, NURTEC ODT, Heplisav-B, BREZTRI.
Industry payments across TX — which companies pay providers there.
